NILUFER DEMIRKAN: Open Payments
NPI 1740876846 · STATEN ISLAND, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,570 in 79 payments from 14 companies in 2025. Trend: 2023 $215 · 2024 $817 · 2025 $1,570
Food & beverage: $1,505Education: $65
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 14 | $359 |
| Galderma Laboratories, L.P. | 15 | $249 |
| UCB, Inc. | 11 | $207 |
| LEO Pharma Inc. | 9 | $191 |
| Botanix SB Inc | 8 | $139 |
| Novartis Pharmaceuticals Corporation | 4 | $91 |
| ABBVIE INC. | 5 | $83 |
| Regeneron Healthcare Solutions, Inc. | 3 | $61 |
| Incyte Corporation | 2 | $42 |
| Lilly USA, LLC | 2 | $42 |
Products named: TREMFYA, Bimzelx, NEMLUVIO, ADBRY, SOFDRA, DUPIXENT, COSENTYX, SKYRIZI.
Industry payments across NY — which companies pay providers there.
